Diarylsulfones as 5-HT2A antagonists
US7468393B2 · kind B2 · utility
0Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2007 |
| Grant date | Dec 23, 2008 |
| Priority date | — |
| Expiry date | Apr 27, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D319/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula I:are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.